Savara Announces New U.S. Health Claims Data Analysis Finds Over 50% Increase in the Estimated Number of Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) Patients Compared to Previous Claims ...
Affordable Care Act insurers approved more claims in 2024, though the improvement remains modest. Nearly one in five in-network claims (19.1%) were denied, leaving millions of Americans with unpaid ...
Retrospective Analysis of U.S. Claims Data Shows AUVI-Q® (epinephrine injection, USP) Prescription Associated with Lower Rates of Anaphylaxis-Related Inpatient Hospitalizations Compared to Other ...
Claims data reveal larger hemoglobin A1c decreases in people with type 2 diabetes who use continuous glucose monitoring and semaglutide compared with semaglutide alone. Study Design: Using US health ...
The primary objectives of this study have been reported elsewhere. 23 There were 2 objectives of the present analysis: 1) construction and validation of a risk model for first severe COPD exacerbation ...
With premiums climbing, benefit leaders rely on claims data and analytic tools to guide smarter plan design and purchasing.
Insurance companies operating in Texas closed almost half the claims filed by homeowners last year without paying anything, part of a rising trend that is shifting more costs onto property owners, ...
Veradigm, which provides clearinghouse services to review and verify claims data accuracy, is at the heart of a data evolution in healthcare. In an interview, Will Barnett, Veradigm Senior Solutions ...
-- Approximately 5,500 Autoimmune PAP Patients in the U.S. Identified in the Updated Analysis that Leveraged a More Recent and Comprehensive Claims Data Source -- -- New England Journal of Medicine ...